Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Anticancer activities of an antimicrobial peptide derivative of Ixosin-B amide.

Hsiao YC, Wang KS, Tsai SH, Chao WT, Lung FD.

Bioorg Med Chem Lett. 2013 Oct 15;23(20):5744-7. doi: 10.1016/j.bmcl.2013.07.063. Epub 2013 Aug 9.

PMID:
23993331
2.

Discovery of potent antimicrobial peptide analogs of Ixosin-B.

Lung FD, Wang KS, Liao ZJ, Hsu SK, Song FY, Liou CC, Wu YS.

Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8. doi: 10.1016/j.bmcl.2012.04.018. Epub 2012 Apr 20.

PMID:
22578463
3.

Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.

Wu YS, Liao ZJ, Wang KS, Lung FD.

Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32. doi: 10.1016/j.bmcl.2013.03.053. Epub 2013 Mar 25.

PMID:
23570790
4.

Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.

Lin MC, Hui CF, Chen JY, Wu JL.

Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004. Epub 2013 Apr 15.

PMID:
23598079
5.

Anti-tumor activities of the host-defense peptide hymenochirin-1B.

Attoub S, Arafat H, Mechkarska M, Conlon JM.

Regul Pept. 2013 Nov 10;187:51-6. doi: 10.1016/j.regpep.2013.10.006. Epub 2013 Oct 31.

PMID:
24185042
6.

Anticancer activity of undecapeptide analogues derived from antimicrobial peptide, brevinin-1EMa.

Kang SJ, Ji HY, Lee BJ.

Arch Pharm Res. 2012 May;35(5):791-9. doi: 10.1007/s12272-012-0505-0. Epub 2012 May 29.

PMID:
22644847
7.

Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.

Hou L, Zhao X, Wang P, Ning Q, Meng M, Liu C.

PLoS One. 2013;8(1):e53491. doi: 10.1371/journal.pone.0053491. Epub 2013 Jan 11.

8.

A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells.

Chen YQ, Min C, Sang M, Han YY, Ma X, Xue XQ, Zhang SQ.

Peptides. 2010 Aug;31(8):1504-10. doi: 10.1016/j.peptides.2010.05.010. Epub 2010 May 21.

PMID:
20493915
9.

Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents.

Wiradharma N, Khoe U, Hauser CA, Seow SV, Zhang S, Yang YY.

Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.

PMID:
21168911
10.

Highly selective end-tagged antimicrobial peptides derived from PRELP.

Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmidtchen A.

PLoS One. 2011 Jan 27;6(1):e16400. doi: 10.1371/journal.pone.0016400.

11.

Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide.

Sioud M, Mobergslien A.

Biochem Pharmacol. 2012 Nov 1;84(9):1123-32. doi: 10.1016/j.bcp.2012.08.002. Epub 2012 Aug 14.

PMID:
22922046
12.

Anticancer β-hairpin peptides: membrane-induced folding triggers activity.

Sinthuvanich C, Veiga AS, Gupta K, Gaspar D, Blumenthal R, Schneider JP.

J Am Chem Soc. 2012 Apr 11;134(14):6210-7. doi: 10.1021/ja210569f. Epub 2012 Mar 28.

13.

A fish antimicrobial peptide, tilapia hepcidin TH2-3, shows potent antitumor activity against human fibrosarcoma cells.

Chen JY, Lin WJ, Lin TL.

Peptides. 2009 Sep;30(9):1636-42. doi: 10.1016/j.peptides.2009.06.009. Epub 2009 Jun 16.

PMID:
19539000
14.

Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog.

Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C.

Peptides. 2012 Jun;35(2):291-9. doi: 10.1016/j.peptides.2012.03.016. Epub 2012 Mar 28.

PMID:
22484288
15.

The effect of C-terminal amidation on the efficacy and selectivity of antimicrobial and anticancer peptides.

Dennison SR, Harris F, Bhatt T, Singh J, Phoenix DA.

Mol Cell Biochem. 2009 Dec;332(1-2):43-50. doi: 10.1007/s11010-009-0172-8. Epub 2009 Jun 10.

PMID:
19513817
16.

Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.

Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C.

Biochimie. 2013 Sep;95(9):1784-94. doi: 10.1016/j.biochi.2013.06.003. Epub 2013 Jun 14.

PMID:
23770440
17.

Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells.

Suttmann H, Retz M, Paulsen F, Harder J, Zwergel U, Kamradt J, Wullich B, Unteregger G, Stöckle M, Lehmann J.

BMC Urol. 2008 Mar 3;8:5. doi: 10.1186/1471-2490-8-5.

18.

In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.

Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS.

J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532. Epub 2013 Jul 26.

PMID:
23893489
19.

Isolation, characterization and anti-cancer activity of SK84, a novel glycine-rich antimicrobial peptide from Drosophila virilis.

Lu J, Chen ZW.

Peptides. 2010 Jan;31(1):44-50. doi: 10.1016/j.peptides.2009.09.028. Epub 2009 Sep 30.

PMID:
19799950
20.

Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.

Yang XH, Xiang L, Li X, Zhao TT, Zhang H, Zhou WP, Wang XM, Gong HB, Zhu HL.

Bioorg Med Chem. 2012 May 1;20(9):2789-95. doi: 10.1016/j.bmc.2012.03.040. Epub 2012 Mar 24.

PMID:
22503364
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk